← Oncology Approval Tracker

FDA DECISION ·

Hepzato Kit

melphalan for injection with hepatic delivery system · Delcath Systems

FDA approvalNew therapyMelanoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Liver-directed therapy for adults with uveal melanoma and unresectable metastases occupying less than 50% of the liver. Extrahepatic disease must be absent or limited to bone, lymph nodes, subcutaneous tissues, or lung and amenable to resection or radiation.

LAMPGEN ANALYSIS

Why it matters

The drug-device combination added a regional treatment for a defined liver-metastatic uveal melanoma population.

What research teams should watch

Document hepatic tumor burden and extrahepatic sites, and coordinate qualified procedural teams and safety oversight.

Related study operations checklist

See the staffing responsibilities, timing, and handoff questions for this study setting.

Liver-directed metastatic uveal melanoma

PRIMARY RECORDS

Sources